DETERMINATION OF THE DNA CROSS-LINKING SEQUENCE SPECIFICITY OF REDUCTIVELY ACTIVATED MITOMYCIN-C AT SINGLE-NUCLEOTIDE RESOLUTION - DEOXYGUANOSINE RESIDUES AT CPG ARE CROSS-LINKED PREFERENTIALLY

被引:77
作者
MILLARD, JT [1 ]
WEIDNER, MF [1 ]
RAUCHER, S [1 ]
HOPKINS, PB [1 ]
机构
[1] UNIV WASHINGTON,DEPT CHEM,SEATTLE,WA 98195
关键词
D O I
10.1021/ja00165a059
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Several synthetic oligodeoxyribonucleotide duplexes containing one or more 5'-CG and/or 5'-GC sites and singly radiolabeled at the 5'- or 3'-termini were subjected to interstrand cross-linking by mitomycin C activated with sodium dithionite in the absence of oxygen. Isolation of the interstrand cross-linked products by polyacrylamide gel electrophoresis (PAGE) was followed by fragmentation with Fe(II) EDTA/hydrogen peroxide/ascorbic acid and analysis of the resulting fragment sizes (by PAGE). It was demonstrated that reductively activated mitomycin C cross-links deoxyguanosine residues at duplex 5'-CG sites in strong preference to duplex 5'-GC sites and numerous A/T-containing sites. The identity of neighboring residues had a significant impact on the relative reactivity toward cross-linking of 5'-CG sites. Constrained molecular mechanics calculations on a model of the monoadduct of reductively activated mitomycin C with N2 of deoxyguanosine in a pentanucleotide duplex indicate a strong preference for the conformation required for cross-linking at 5'-CG over that for 5'-GC. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:3637 / 3641
页数:5
相关论文
共 37 条
  • [1] Arnott S., 1976, HDB BIOCHEMISTRY MOL, VII, P411
  • [2] DEOXYNUCLEOSIDE PHOSPHORAMIDITES - A NEW CLASS OF KEY INTERMEDIATES FOR DEOXYPOLYNUCLEOTIDE SYNTHESIS
    BEAUCAGE, SL
    CARUTHERS, MH
    [J]. TETRAHEDRON LETTERS, 1981, 22 (20) : 1859 - 1862
  • [3] DNA CROSSLINKING, SISTER-CHROMATID EXCHANGE AND SPECIFIC-LOCUS MUTATIONS
    CARRANO, AV
    THOMPSON, LH
    STETKA, DG
    MINKLER, JL
    MAZRIMAS, JA
    FONG, S
    [J]. MUTATION RESEARCH, 1979, 63 (01): : 175 - 188
  • [4] CARTER SK, 1968, CANCER CHEMOTH REP 3, V1, P99
  • [5] CHAWLA AK, 1987, STRUCTURE EXPRESSION, V2
  • [6] MITOMYCIN-C - REVIEW
    CROOKE, ST
    BRADNER, WT
    [J]. CANCER TREATMENT REVIEWS, 1976, 3 (03) : 121 - 139
  • [7] GILONI L, 1981, J BIOL CHEM, V256, P8608
  • [8] GOLDBERG IH, 1971, ANNU REV BIOCHEM, V40, P445
  • [9] STRUCTURE OF THE ANTHRAMYCIN-D(ATGCAT)2 ADDUCT FROM ONE-DIMENSIONAL AND TWO-DIMENSIONAL PROTON NMR EXPERIMENTS IN SOLUTION
    GRAVES, DE
    STONE, MP
    KRUGH, TR
    [J]. BIOCHEMISTRY, 1985, 24 (26) : 7573 - 7581
  • [10] HASHIMOTO Y, 1983, CHEM PHARM BULL, V31, P861